Earnings Feed
Start Free
Home/Filings/4/0001437749-10-001101
4//SEC Filing

Miceli James T 4

Accession 0001437749-10-001101

CIK 0001375623other
View on SEC.govCompany Profile

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 5:50 PM ET

Size

35.5 KB

Accession

0001437749-10-001101

Insider Transaction Report

Form 4
Period: 2007-11-13
IMMUNOSYN CORPIMYN
Miceli James T
10% Owner
Transactions
  • Purchase

    Common Stock

    2009-07-07$0.07/sh+10,000$700→ 510,000 total
  • Purchase

    Common Stock

    2009-07-08$0.08/sh+21,500$1,720→ 531,500 total
  • Purchase

    Common Stock

    2009-06-30$0.07/sh+50,000$3,500→ 688,000 total
  • Purchase

    Common Stock

    2009-07-14$0.09/sh+30,000$2,700→ 730,857 total
  • Purchase

    Common Stock

    2009-07-08$0.09/sh+15,000$1,350→ 546,500 total
  • Purchase

    Common Stock

    2009-07-14$0.09/sh+10,000$900→ 576,500 total
  • Purchase

    Common Stock

    2009-07-20$0.08/sh+12,780$1,022→ 743,637 total
  • Purchase

    Common Stock

    2009-08-31$0.05/sh+100,000$5,000→ 1,073,137 total
  • Purchase

    Common Stock

    2009-07-13$0.08/sh+10,000$800→ 556,500 total
  • Purchase

    Common Stock

    2009-07-14$0.10/sh+10,000$950→ 566,500 total
  • Purchase

    Common Stock

    2009-07-15$0.09/sh+51,500$4,635→ 628,000 total
  • Purchase

    Common Stock

    2009-07-15$0.10/sh+10,000$950→ 638,000 total
  • Purchase

    Common Stock

    2009-07-06$0.06/sh+2,857$171→ 690,857 total
  • Purchase

    Common Stock

    2009-07-22$0.08/sh+50,000$4,000→ 793,637 total
  • Purchase

    Common Stock

    2009-07-28$0.07/sh+50,000$3,500→ 896,137 total
  • Other

    Common Stock

    2007-11-13+500,000→ 500,000 total
  • Other

    Common Stock

    2007-11-13+12,710,000→ 85,634,180 total(indirect: By Spouse)
  • Purchase

    Common Stock

    2009-07-22$0.07/sh+2,500$175→ 796,137 total
  • Purchase

    Common Stock

    2009-07-27$0.07/sh+50,000$3,500→ 846,137 total
  • Purchase

    Common Stock

    2009-08-26$0.06/sh+77,000$4,620→ 973,137 total
  • Purchase

    Common Stock

    2009-07-10$0.09/sh+10,000$900→ 700,857 total
Holdings

  • Common Stock

    (indirect: by entities)
    85,634,180

  • Common Stock

    (indirect: By Spouse)
    12,710,000
Footnotes (5)
  • [F1]Represents change in form of ownership by transfer and distribution from Cuxhaven Holdings Ltd., which was wholly owned by the reporting person.
  • [F2]Represents change in form of ownership by wife of reporting person by transfer and distribution from Cuxhaven Holdings Ltd., which was wholly owned by the reporting person. The reporting person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or any other purposes.
  • [F3]Purchased in the reporting person's 401(k) plan account.
  • [F4]Purchased in the reporting person's IRA account.
  • [F5]Indirect interests owned by Argyll Biotechnologies LLC, Argyll Equities LLC and Padmore Holdings, Ltd. in which the reporting person owns ownership interests. Indirect ownership reported reflects reporting person's proportionate interest.

Documents

1 file

Issuer

IMMUNOSYN CORP

CIK 0001375623

→
Entity typeother

Related Parties

1
  • filerCIK 0001385168

Filing Metadata

Form type
4
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 5:50 PM ET
Size
35.5 KB
View on SEC.gov